Literature DB >> 26458933

Surgical treatment of sacral chordoma: survival and prognostic factors.

C Ruosi1, G Colella2, S L Di Donato2, F Granata2, M G Di Salvatore3, F Fazioli3.   

Abstract

INTRODUCTION: Sacral chordoma is a rare low-to-intermediate grade malignant tumour. The mainstay of treatment is still surgery with en bloc and wide resection margins, which can grant the best chances of a long-term control or cure of this disease. The first aim of this paper is to collect data about survival, time to local recurrence and metastasis among patients affected by sacral chordoma and primarily treated with surgery. The second aim is to analyze the influence of level resection, tumor volume and surgical margins on local recurrence.
MATERIALS AND METHODS: The study population was composed of 14 patients treated with sacral chordoma resection at the National Tumour Institute of Naples-Pascale (Italy) from January 2000 to June 2013. The median follow-up was 84 months (range 24-132 months). The follow-up was characterized by: standard radiographs, MRI, and a CT scan of the chest annually. Time to recurrence or metastasis was calculated from the date of resection to the date of diagnosis of first recurrence or metastasis.
RESULTS: Out of all the patients, six died (42.86 %) during the follow-up; 6 (42.86 %) had local recurrence; 4 (28.57 %) had metastasis. At univariate analysis wide surgical margins (R0) were associated with increased survival up to a local recurrence (OR = 0.0286; 95 % CI = 0.0014-0.5739; P = 0.026); the level of resection (OR = 3.33; 95 % CI = 0.3619-30.7025; P = 0.592) and tumour volume (P = 1) did not show a statistically significant correlation. DISCUSSION: Based on our experience, we hope all patients to be treated by surgery, the only good standard treatment of this disease. The resection should result in margins as wide as possible. For these reasons, it is essential for this disease to be treated in highly specialized centres because only a complete surgery can offer a chance to care for these patients.
CONCLUSIONS: Solid survival at long-term follow-up can be achieved by a surgical resection performed with wide margins.

Entities:  

Keywords:  Prognostic factor; Sacral chordoma; Surgical resection; Survival

Mesh:

Year:  2015        PMID: 26458933     DOI: 10.1007/s00586-015-4276-4

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  17 in total

1.  Oncologic and functional outcome following sacrectomy for sacral chordoma.

Authors:  Christopher A Hulen; H Thomas Temple; William P Fox; Andrew A Sama; Barth A Green; Frank J Eismont
Journal:  J Bone Joint Surg Am       Date:  2006-07       Impact factor: 5.284

2.  Operative management of sacral chordoma.

Authors:  Bruno Fuchs; Ian D Dickey; Michael J Yaszemski; Carrie Y Inwards; Franklin H Sim
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

3.  Sacral chordoma: 40-year experience at a major cancer center.

Authors:  J E York; A Kaczaraj; D Abi-Said; G N Fuller; J M Skibber; N A Janjan; Z L Gokaslan
Journal:  Neurosurgery       Date:  1999-01       Impact factor: 4.654

4.  Chordoma: long-term follow-up after radical photon irradiation.

Authors:  C Catton; B O'Sullivan; R Bell; N Laperriere; B Cummings; V Fornasier; J Wunder
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.

Authors:  P Bergh; L G Kindblom; B Gunterberg; F Remotti; W Ryd; J M Meis-Kindblom
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

7.  Prognostic Factors in the Operative Management of Sacral Chordomas.

Authors:  Babar Kayani; Mathew David Sewell; Kimberly-Anne Tan; Sammy A Hanna; Richard Williams; Robin Pollock; John Skinner; Timothy W R Briggs
Journal:  World Neurosurg       Date:  2015-06-23       Impact factor: 2.104

8.  Lumbosacral chordoma. Prognostic factors and treatment.

Authors:  E Y Cheng; R A Ozerdemoglu; E E Transfeldt; R C Thompson
Journal:  Spine (Phila Pa 1976)       Date:  1999-08-15       Impact factor: 3.468

9.  Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases.

Authors:  I R Samson; D S Springfield; H D Suit; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1993-10       Impact factor: 5.284

Review 10.  Chordoma: the nonsarcoma primary bone tumor.

Authors:  Rashmi Chugh; Hussein Tawbi; David R Lucas; J Sybil Biermann; Scott M Schuetze; Laurence H Baker
Journal:  Oncologist       Date:  2007-11
View more
  11 in total

1.  Letter to the Editor concerning "Surgical treatment of sacral chordoma: survival and prognostic factors" by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912-S917.

Authors:  Ming-Xiang Zou; Guo-Hua Lv; Xiao-Bin Wang; Jing Li
Journal:  Eur Spine J       Date:  2016-10-18       Impact factor: 3.134

2.  Whole-transcriptome analysis of chordoma of the skull base.

Authors:  Diana Bell; Shaan M Raza; Achim H Bell; Gregory N Fuller; Franco DeMonte
Journal:  Virchows Arch       Date:  2016-07-11       Impact factor: 4.064

Review 3.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "surgical and research" articles in the European Spine Journal, 2017.

Authors:  Robert C Mulholland
Journal:  Eur Spine J       Date:  2018-01-08       Impact factor: 3.134

4.  Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features.

Authors:  Ping Yin; Ning Mao; Chao Zhao; Jiangfen Wu; Chao Sun; Lei Chen; Nan Hong
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

5.  Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute.

Authors:  Yongkun Yang; Xiaohui Niu; Yuan Li; Weifeng Liu; Hairong Xu
Journal:  Eur Spine J       Date:  2016-12-09       Impact factor: 3.134

6.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

7.  Cervical chordomas: multicenter case series and meta-analysis.

Authors:  Oluwaseun O Akinduro; Diogo P Garcia; Ricardo A Domingo; Tito Vivas-Buitrago; Bernardo Sousa-Pinto; Mohamad Bydon; Michelle J Clarke; Ziya L Gokaslan; Maziyar A Kalani; Kingsley Abode-Iyamah; Alfredo Quiñones-Hinojosa
Journal:  J Neurooncol       Date:  2021-04-03       Impact factor: 4.130

8.  A case-control study of computer navigation assisted resection of primary sacral chordoma above sacrum 3 level.

Authors:  Yongkun Yang; Yuan Li; Qing Zhang; Xiaohui Niu
Journal:  J Bone Oncol       Date:  2020-06-20       Impact factor: 4.072

9.  Adjuvant gamma knife surgery and image-guided, intensity-modulated radiation therapy for the treatment of sacral chordomas.

Authors:  Shun Lu; Xinhao Peng; Bingwen Zou; Cheng Zhou; Mei Feng; Jinyi Lang
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-22

10.  Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients With Long-Term Follow-Up.

Authors:  Scott L Zuckerman; Sun-Ho Lee; George J Chang; Garrett L Walsh; Reza J Mehran; Ziya L Gokaslan; Ganesh Rao; Claudio E Tatsui; Laurence D Rhines
Journal:  Global Spine J       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.